Pulmonary Disease, Chronic Obstructive Clinical Trial
— COReOfficial title:
COPD Online Rehabilitation (CORe) - a Randomized, Multicenter Telemedicine Intervention Study
| Verified date | March 2020 |
| Source | University Hospital Bispebjerg and Frederiksberg |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
International and national publications emphasize that COPD rehabilitation is a key
cornerstone in the standard treatment of COPD, based on more than 15 years of research in
COPD rehabilitation. COPD rehabilitation improves quality of life, anxiety and depression and
physical function. COPD rehabilitation including special physical training, patient-directed
education and smoking cessation is core rehabilitation elements, which today are recommended
as mandatory content in standard COPD rehabilitation.
Standard COPD rehabilitation is an established offer in all regions and municipalities in
Denmark. It is however a well-known challenge, that persons with the most severe COPD
symptoms and co-morbidities are most likely not to receive COPD rehabilitation. Frequent
exacerbations, socially isolation, transport distance to rehabilitation are main reasons why
people with severe COPD disease deliberately chooses not to receive COPD rehabilitation. Why
there at present are no rehabilitation alternatives for patients with the most severe COPD
symptoms, supervised COPD Online rehabilitation in groups, delivered by health professionals
in the COPD patients' own home via a computer screen could likely encourage more people to
participate. The number of RCT's investigating the effect of supervised Online delivered COPD
rehabilitation in groups versus established COPD rehabilitation are very limited.
The purpose of this randomized study is to investigate the short-term and long-term efficacy
of 10 weeks of online COPD rehabilitation versus conventional supervised COPD rehabilitation
in people with severe and very severe COPD. The outcome of the intervention is measured on
walking distance, muscle endurance, activity level, quality of life and COPD symptoms
respectively. Outcomes are measures before intervention start, end of intervention. This
study also collects follow-up update after 3, 6 and 12 month. The follow-up data will be in
separate publication.
Hypothesis
1. COPD online rehabilitation provides significant larger improvements than the usual care
on walking distance, muscle endurance, activity level, and quality of life and COPD
symptoms in people with severe and very severe COPD.
2. COPD online rehabilitation and conventional COPD rehabilitation, provides clinically
relevant improvement on walking distance, muscle endurance, activity level, quality of
life and COPD symptoms in people with severe and very severe COPD.
| Status | Completed |
| Enrollment | 134 |
| Est. completion date | December 31, 2019 |
| Est. primary completion date | December 31, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Clinical diagnosis of COPD defined as a ratio of forced expiratory volume at one second (FEV1) to forced vital capacity < 0.70 - FEV1 <50%, corresponding to severe or very severe COPD - Symptoms equivalent to the Medical Research Council (MRC) from 2 to 5 Exclusion Criteria: - Concurrent participation in or recent completion of pulmonary rehabilitation within the last six months. - Dementia/ Cognitive impairment or uncontrolled psychiatric illness, - An impaired hearing and / or vision which causes the instructions in the rehabilitation is not understood. - Unable to understand and / or speak Danish. - Unable to read Danish. - Severe co-morbidity that are contraindicated to rhe clinical exercise protocol. |
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Amager Hospital | Copenhagen | |
| Denmark | Bispebjerg and Frederiksberg Hospital | Copenhagen | Copenhagen Northwest |
| Denmark | Frederikssund hospital | Frederikssund | |
| Denmark | Gentofte Hospital | Hellerup | |
| Denmark | Herlev Hospital | Herlev | |
| Denmark | Hillerød hospital | Hillerød | |
| Denmark | Hvidovre Hospital | Hvidovre |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital Bispebjerg and Frederiksberg | Danish Lung Association, Region Capital Denmark, TrygFonden, Denmark, University of Copenhagen |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in 6-Minute Walk Test Distance (6MWT) | In-clinic test that measures exercise capacity | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in 30 second sit-to-stand test (30-STST) | In-clinic test that measures muscle endurance/strength | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in Activity level (ActivPAL) | Worn by the patients around the clock for 5 days in a private home. | Worn by the patients around the clock for 5 days in a private home at baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in Clinical COPD Questionaire (CCQ) | Patient completed questionnaires that assess quality of life and COPD symptoms. Ten Item questionaire with total score from 0-60 points. | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in COPD Assessment Test (CAT) | Patient completed questionnaires that assess quality of life and COPD symptoms. Five item questionaire with total score from 0-40 points. | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in Hospital Anxiety and Depression Scale (HADS) | Patient completed questionnaires that assess anxiety and depression symptoms. Seven item domain questions for depression with total score form 0-21 point. Seven item domain questions for anxiety with total score fra 0-21 points. Total score from 0-42 points | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Change in Euro Qol (EQ5D) | Patient completed questionnaires that assess quality of life. Total score fra 0-1 on EQ5D-health domain. Total score from 0-100mm on EQ5D-vas domain. No total domain score | baseline (before intervention), after 10 weeks, after 22 weeks (average of 3 month follow up) | |
| Secondary | Total attendance in rehabilitation | registered | after 10 weeks | |
| Secondary | number of hospital admissions | from registers | number of hospital admissions - after 10 weeks, after 22 weeks (average of 3 month follow up), after 36 weeks (average of 6 month follow up), after 62 weeks (average of 12 month follow up) | |
| Secondary | Number of hospital days | from registers | number of hospital days - after 10 weeks, after 22 weeks (average of 3 month follow up), after 36 weeks (average of 6 month follow up), after 62 weeks (average of 12 month follow up) | |
| Secondary | Outpatient visits in hospital and at general practioner | from registers | number of outpatients visits in hospital and at general practioner - after 10 weeks, after 22 weeks (average of 3 month follow up), after 36 weeks (average of 6 month follow up), after 62 weeks (average of 12 month follow up) | |
| Secondary | Mortality | from registers | after 10 weeks, after 22 weeks (average of 3 month follow up), after 36 weeks (average of 6 month follow up), after 62 weeks (average of 12 month follow up) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
| Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
| Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
| Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
| Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
| Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
| Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
| Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
| Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
| Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
| Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
| Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
| Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
| Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|